Using expired medication to restart at a lower dose is still not advisable
[1] [3] Administered as a once-weekly subcutaneous injection, it works by mimicking the action of the naturally occurring hormone GLP-1, which helps regulate blood glucose levels by stimulating insulin secretion, suppressing glucagon release, and slowing gastric emptying
"The risk of developing these severe side effects is very small, but it is important that patients and healthcare professionals are aware and alert to the associated symptoms." In the UK, the most commonly used GLP-1 therapies are Novo Nordisk's semaglutide-based Ozempic for diabetes and Wegovy for obesity, as well as Eli Lilly's Mounjaro (tirzepatide), which are all given as weekly injections
While its true that some individuals experience weight regain after coming off GLP-1 therapy, its not inevitable
These are often described as either purging or breakouts, but they are not the same